Here, we compared the performance of the Cobas® EGFR v2 test with the novel UltraSEEKTM Lung Panel on the MassARRAY® System on routine clinical samples of NSCLC patients. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.